|
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails
Xconomy … has shut down operations after the startup's only drug candidate failed in a mid-stage clinical trial against asthma, Xconomy has learned. … |
View full post on asthma – Google News